Neurovo began in 2016 as Ketamine Media, founded by Chris and Cassy to support pioneering clinicians offering ketamine therapy. Recognizing the unique challenges in marketing treatments like ketamine, TMS, and SPRAVATO®, Neurovo has evolved into the industry's leading growth partner exclusively serving these practices. With experience from over 350 clinics worldwide, they've developed deep expertise in patient acquisition, regulatory compliance, and operational alignment, ensuring clinics can fill calendars and provide life-changing care. Their mission is to bridge the gap between innovative clinics and patients in need, navigating complex advertising regulations while adapting to the evolving landscape of interventional psychiatry. Neurovo's name reflects this commitment—to spark new beginnings and possibilities in mental health treatment.